about
NK cells and HIV infection: lessons from other viruses.Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen.Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation.Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.In vitro non-productive infection of purified natural killer cells by the BRU isolate of the human immunodeficiency virus type 1.In vivo adriamycin-induced apoptosis in peritoneal murine macrophages: partial participation of a caspase cascade.Reduction of death receptor 5 expression and apoptosis of CD4+ T cells from HIV controllers.Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model.Partial restoration of cytokine profile despite reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients during highly active antiretroviral treatment.Natural resistance to HIV infection: lessons learned from HIV‐exposed uninfected individuals.[Cryptococcal meningo-encephalitis in an apparently immunocompetent patient]S100A9 protein is a novel ligand for the receptor CD85j and their interaction is implicated in the NK cell-mediated control of HIV-1 replication.Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients.Preferential replication of HIV-1 in memory CD4+ subpopulation.Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemiaSerum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patientsExtensive analysis of lymphocyte subsets in normal subjects by three-color immunofluorescenceSpecific suppression of the in vitro parent anti-hybrid reaction. I. Characterization of a suppressor cell induced in hybrids by pretreatment with parent-strain spleen cellsViral superantigen-induced hyporesponsiveness of T cells and polyclonal B cell activation in HIV-1 infectionImplication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammationHuman apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharideCD4 T cell recovery is slower in patients experiencing viral load rebounds during HAARTFunctional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemiaEx vivo characterization of human thymic dendritic cell subsetsHIV-1 induced decrease of nitric oxide production and inducible nitric oxide synthase expression during in vivo and in vitro infectionInduction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriersGamma-irradiation induced apoptosis in peritoneal macrophages by oxidative stress. Implications of antioxidants in caspase mitochondrial pathwaySystemic immune activation in HIV-1-exposed uninfected Vietnamese intravascular drug usersHigh Activation of γδ T Cells and the γδ2pos T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NKγδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activationChanges in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
P50
Q35014665-F387D7BA-D2D0-476C-8B0C-949DB7E99833Q36363835-FD5EA63C-0156-44BA-ACD3-76940928EF4CQ37620833-CAD2B6D3-79F8-4349-AF26-A6D610E41BB3Q38909215-C542E799-7BE6-4B5D-89EF-EB76AB2D55FEQ39310147-1B727F6A-86A6-4127-ACC7-BAFE0DD27B61Q40334650-23C11D0C-1546-4FCA-8D79-F47DDF24CA4FQ41254312-BE0DDD98-58EB-454E-9036-70583633A059Q41561746-042D5AE5-2D5C-4421-A442-A9101C387588Q42166850-EC10B65B-D52C-4167-8B57-5654FDD4DB78Q42200792-2F3546DD-8B83-4C8D-B4E9-62EFA57E35BDQ42236065-95EF4DA7-5EE7-4A43-8457-215E95A85F7CQ45068083-31C06393-C529-45F1-95CE-BCC9440ED108Q45728556-9C9D7026-18CB-413F-A9DE-39370019C586Q46428730-691B0E19-8436-4AF4-9348-53B7BF86CF68Q46976278-53054D07-F369-4BD8-9A48-61DE804C90FEQ46985672-55A14313-584F-45CC-A745-D4B2E82D2CF8Q52066095-1F297EB9-4D73-4DFB-8BB3-0B39B6A74940Q52105367-99B581BE-7161-4F10-8786-8093BA8327E5Q58484362-FFD16175-2EB4-4C28-BA58-C96B99878CA5Q68307347-8619262F-5F48-4EFD-B4B6-66176BFF3BB3Q68323825-06A91973-7E41-4F85-8D2A-10DA81F8C50BQ70023471-B3B1E19F-3B53-4793-9139-6A855F0F7763Q72797884-3C7BB5E1-C105-427C-AEA4-35627C263B9BQ74144043-73E43AEB-E10C-4BF5-8CD1-FF49723FD72CQ75364784-21ED7CAD-D3A7-48B7-9CF6-E2E1C2F4986DQ77154363-C9D53405-C10D-4633-AB92-9AD015FA3A80Q77637141-1679B5B0-F4FC-49D1-B980-FD578BD321E6Q80106635-A50E81AB-E296-400F-BC55-765BDFA1A676Q80459612-2D4E928F-1DAF-47D1-BB6E-F33AEFE26D67Q80594566-EF696201-4AB1-4353-8C9C-88E12CEFF0D8Q81533555-FFC7E03C-6F70-4356-AD09-DFD67102CC13Q82867152-0A3F87E7-0E1E-485F-B7F6-538F427FCFB9Q90050669-0A33AB36-36BF-46D7-BF43-E1469818FB46Q92356608-1E652521-FB5B-4CDC-BB4D-C253EED40D6BQ92921954-F45E0586-4F13-469F-82C9-D979BF0E733EQ93483929-1D2B76BC-7932-4AF9-BD6D-CFE9D53A41E4
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
D Scott-Algara
@ast
D Scott-Algara
@en
D Scott-Algara
@es
D Scott-Algara
@nl
type
label
D Scott-Algara
@ast
D Scott-Algara
@en
D Scott-Algara
@es
D Scott-Algara
@nl
prefLabel
D Scott-Algara
@ast
D Scott-Algara
@en
D Scott-Algara
@es
D Scott-Algara
@nl
P31
P496
0000-0003-1851-503X